Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 112Other hematologic neoplasm 92Myeloid 41Plasma cell 32Sarcoma 21Classical hematology 21Dermatologic 15Genitourinary 11CNS 9Thoracic 5Gynecologic 5Breast 4Other neoplasm 2Head & Neck 2Gastrointestinal 2Tumor-Agnostic 1Other solid neoplasm 1

Conditions

Radiation Injuries 1Oropharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Cranial Nerve Diseases 1

Interventions

Cisplatin 619pembrolizumab 323Radiotherapy 319Cetuximab 274Docetaxel 220Radiotherapy, Intensity-Modulated 210Carboplatin 197Fluorouracil 196Paclitaxel 159Nivolumab 138Gemcitabine 124Magnetic Resonance Spectroscopy 94Radiation 85Drug Therapy 77Capecitabine 76toripalimab 74Surgical Procedures, Operative 62durvalumab 60Biopsy 52Cyclophosphamide 48Chemoradiotherapy 47camrelizumab 46Specimen Handling 46Erlotinib Hydrochloride 46Radiosurgery 45130-nm albumin-bound paclitaxel 43tislelizumab 42Standard of Care 42Platinum 41Bevacizumab 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Methylprednisolone × Head & Neck × Clear all
NCT04151082 2026-01-13

High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
35 enrolled
Head & Neck

Cranial Nerve Diseases, Oropharyngeal Neoplasms

NCT01621880 2019-01-09

BRAIN

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Completed
112 enrolled 10 charts
Head & Neck

Nasopharyngeal Carcinoma, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡